Catalyst Wire Dossier Catalyst Wire Dossier

SANDOSTATIN LAR DEPOT

OCTREOTIDE ACETATE · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for SANDOSTATIN LAR DEPOT, covering 2006-05-10 to 2024-07-11. Get the full timeline:

Most recent: FDA Approved: SANDOSTATIN LAR DEPOT — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing